Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Lisa Lohr"'
Autor:
Pirow Bekker, Daniel Dairaghi, Lisa Seitz, Manmohan Leleti, Yu Wang, Linda Ertl, Trageen Baumgart, Sarah Shugarts, Lisa Lohr, Ton Dang, Shichang Miao, Yibin Zeng, Pingchen Fan, Penglie Zhang, Daniel Johnson, Jay Powers, Juan Jaen, Israel Charo, Thomas J Schall
Publikováno v:
PLoS ONE, Vol 14, Iss 1, p e0210593 (2019)
[This corrects the article DOI: 10.1371/journal.pone.0164646.].
Externí odkaz:
https://doaj.org/article/a84a81f1520c4d6e9e34354e7c569191
Autor:
Pirow Bekker, Daniel Dairaghi, Lisa Seitz, Manmohan Leleti, Yu Wang, Linda Ertl, Trageen Baumgart, Sarah Shugarts, Lisa Lohr, Ton Dang, Shichang Miao, Yibin Zeng, Pingchen Fan, Penglie Zhang, Daniel Johnson, Jay Powers, Juan Jaen, Israel Charo, Thomas J Schall
Publikováno v:
PLoS ONE, Vol 11, Iss 10, p e0164646 (2016)
The complement 5a receptor has been an attractive therapeutic target for many autoimmune and inflammatory disorders. However, development of a selective and potent C5aR antagonist has been challenging. Here we describe the characterization of CCX168
Externí odkaz:
https://doaj.org/article/cc8d52d98d57413ea3878ceea94d7d27
Autor:
Lisa Lohr
Publikováno v:
Oncology Times. 41:7-37
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4648089bbbf459b4b4092b2cde0ce0b8
https://doi.org/10.1097/01.cot.0000557601.62948.0a
https://doi.org/10.1097/01.cot.0000557601.62948.0a
Autor:
Lisa Lohr
Publikováno v:
Oncology Times. 41:19-21
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a69aa75131be447484748fb7477f4138
https://doi.org/10.1097/01.cot.0000586272.22519.33
https://doi.org/10.1097/01.cot.0000586272.22519.33
Autor:
Lisa Lohr
Publikováno v:
Oncology Times. 41:8
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d4063fa0dbbe8dbde83567084a7e2520
https://doi.org/10.1097/01.cot.0000569312.73447.9b
https://doi.org/10.1097/01.cot.0000569312.73447.9b
Autor:
Daniel J. Dairaghi, Jay P. Powers, Juan C. Jaen, Trageen Baumgart, Yu Wang, Israel F. Charo, Ton Dang, Sarah Shugarts, Lisa Seitz, Daniel Johnson, Yibin Zeng, Lisa Lohr, Linda S. Ertl, Penglie Zhang, Pingchen Fan, Pirow Bekker, Manmohan Reddy Leleti, Thomas J. Schall, Shichang Miao
Publikováno v:
PLoS ONE
PLoS ONE, Vol 11, Iss 10, p e0164646 (2016)
PLoS ONE, Vol 11, Iss 10, p e0164646 (2016)
The complement 5a receptor has been an attractive therapeutic target for many autoimmune and inflammatory disorders. However, development of a selective and potent C5aR antagonist has been challenging. Here we describe the characterization of CCX168
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e121ebccfd3be3946f666bdcc6c14a1
https://pubmed.ncbi.nlm.nih.gov/30608991
https://pubmed.ncbi.nlm.nih.gov/30608991
Autor:
Jeff A. Engle, Lisa Lohr
Publikováno v:
Oncology Times. 39:1-10
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2dad52193da996015289ffde6414c7f3
https://doi.org/10.1097/01.cot.0000527359.20255.08
https://doi.org/10.1097/01.cot.0000527359.20255.08
Autor:
Lisa Lohr
Publikováno v:
Oncology Times. 40:30-30
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c1347d40a2d7741a877521e5fc59ca77
https://doi.org/10.1097/01.cot.0000547482.07262.92
https://doi.org/10.1097/01.cot.0000547482.07262.92
Autor:
Lisa Lohr
Publikováno v:
Oncology Times. 40:10
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::97f8903207cc3ae9a8a851d651d5a066
https://doi.org/10.1097/01.cot.0000546177.14474.78
https://doi.org/10.1097/01.cot.0000546177.14474.78
Autor:
Lisa Lohr
Publikováno v:
Oncology Times. 40:12-12
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6e16eafc99d26520fed176065cc77b56
https://doi.org/10.1097/01.cot.0000531949.12609.f1
https://doi.org/10.1097/01.cot.0000531949.12609.f1